2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium Sodium Salt - CAS 150849-52-8
Catalog: |
BB010583 |
Product Name: |
2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium Sodium Salt |
CAS: |
150849-52-8 |
Synonyms: |
sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)-5-tetrazol-3-iumyl]benzene-1,3-disulfonate; sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-3-ium-5-yl]benzene-1,3-disulfonate |
IUPAC Name: | sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-3-ium-5-yl]benzene-1,3-disulfonate |
Description: | A highly sensitive tetrazolium reagent (light red) that produces a water-soluble formazan (dark red color) in NADH and cell proliferation assays due to cleavage by mitochondrial dehydrogenase.WST-1 formazan l max = 438nm; e= 3.7 x 104. |
Molecular Weight: | 651.34 |
Molecular Formula: | C19H11IN5O8S2Na |
Canonical SMILES: | C1=CC(=CC=C1N2N=C(N=[N+]2C3=CC=C(C=C3)[N+](=O)[O-])C4=C(C=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])I.[Na+] |
InChI: | InChI=1S/C19H12IN5O8S2.Na/c20-12-1-3-13(4-2-12)23-21-19(22-24(23)14-5-7-15(8-6-14)25(26)27)17-10-9-16(34(28,29)30)11-18(17)35(31,32)33;/h1-11H,(H-,28,29,30,31,32,33);/q;+1/p-1 |
InChI Key: | JUJBNYBVVQSIOU-UHFFFAOYSA-M |
Solubility: | Soluble in water (10 mg/ml) |
Appearance: | Light yellow to light brown powder |
LogP: | 4.21680 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
KR-102168783-B1 | Small interfering rna inhibition of hantaan virus infection and composition for treatment comprising thereof | 20200420 |
WO-2021170290-A1 | Inhibitors of human deubiquitinases for the treatment of coronaviral infections | 20200228 |
KR-20210102602-A | Hyaluronic acid hydrogel stabilizing a bio-active substance and the method for preparing the same | 20200212 |
CN-111235220-A | Detection kit for inhibiting and generating superoxide anion free radicals | 20200123 |
WO-2021113822-A1 | Companion diagnostics for complement inhibitors | 20191206 |
PMID | Publication Date | Title | Journal |
32128977 | 20200701 | Indomethacin decreases insulin secretion by reducing KCa3.1 as a biomarker of pancreatic tumor and causes apoptotic cell death | Journal of biochemical and molecular toxicology |
31260663 | 20190901 | Effects of simvastatin on matrix metalloproteinase regulation in IL-1β-induced SW1353 cells | Chemico-biological interactions |
31194954 | 20190825 | β-2-Himachalen-6-ol inhibits 4T1 cells-induced metastatic triple negative breast carcinoma in murine model | Chemico-biological interactions |
30769050 | 20190401 | The protective effects of the antioxidant N-acetylcysteine (NAC) against oxidative stress-associated apoptosis evoked by the organophosphorus insecticide malathion in normal human astrocytes | Toxicology |
29992829 | 20190101 | Anticarcinogenic effect of indole-3-carbinol (I3C) on human hepatocellular carcinoma SNU449 cells | Human & experimental toxicology |
Complexity: | 942 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 650.89915 |
Formal Charge: | 0 |
Heavy Atom Count: | 36 |
Hydrogen Bond Acceptor Count: | 10 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 650.89915 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 212 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS